Tags

Type your tag names separated by a space and hit enter

National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management.
Infect Dis Rep. 2020 Feb 25; 12(1):8543.ID

Abstract

On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The "L. Spallanzani" National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data.

Authors+Show Affiliations

National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32218915

Citation

Nicastri, Emanuele, et al. "National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 Clinical Management." Infectious Disease Reports, vol. 12, no. 1, 2020, p. 8543.
Nicastri E, Petrosillo N, Ascoli Bartoli T, et al. National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep. 2020;12(1):8543.
Nicastri, E., Petrosillo, N., Ascoli Bartoli, T., Lepore, L., Mondi, A., Palmieri, F., D'Offizi, G., Marchioni, L., Murachelli, S., Ippolito, G., & Antinori, A. (2020). National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management. Infectious Disease Reports, 12(1), 8543. https://doi.org/10.4081/idr.2020.8543
Nicastri E, et al. National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 Clinical Management. Infect Dis Rep. 2020 Feb 25;12(1):8543. PubMed PMID: 32218915.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management. AU - Nicastri,Emanuele, AU - Petrosillo,Nicola, AU - Ascoli Bartoli,Tommaso, AU - Lepore,Luciana, AU - Mondi,Annalisa, AU - Palmieri,Fabrizio, AU - D'Offizi,Gianpiero, AU - Marchioni,Luisa, AU - Murachelli,Silvia, AU - Ippolito,Giuseppe, AU - Antinori,Andrea, Y1 - 2020/03/16/ PY - 2020/03/16/received PY - 2020/03/16/accepted PY - 2020/3/29/entrez PY - 2020/3/29/pubmed PY - 2020/3/29/medline KW - COVID-19 KW - SARS-CoV-2 KW - Treatment SP - 8543 EP - 8543 JF - Infectious disease reports JO - Infect Dis Rep VL - 12 IS - 1 N2 - On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The "L. Spallanzani" National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. SN - 2036-7430 UR - https://www.unboundmedicine.com/medline/citation/32218915/full_citation L2 - https://doi.org/10.4081/idr.2020.8543 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.